KMT2A and acute leukemia: In conclusion, we strongly believe that the genes identified in the present study represent genes which directly and readily respond to the loss of the MLL-AF4, MLL-ENL, or AF4-MLL, and that these genes potentially include attractive therapeutic targets and provide important insights into the biology underlying MLL-rearranged acute leukemias.